Miltenyi Biotec
Miltenyi Biotec home - back to start page
Miltenyi BiotecMiltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
Miltenyi Biotec
navigation Sample preparation
navigation Cell separation
navigation Cell analysis
navigation Cell culture
navigation Molecular applications
Miltenyi Biotec
Miltenyi Links
Miltenyi Home
MACS Cytokines
MACS Cell Analysis
Tissue Dissociation
Neuroscience
Genomic Services
Miltenyi Biotec
Stemolecule™ SHH Antagonist
Description
Stemolecule™ SHH Antagonist is an inhibitor of Sonic hedgehog signaling (SHH)1. Hedgehog signaling plays key roles in a wide variety of development process2 as well as cancer progression3. The vertebrate family of hedgehog genes that have been identified are known as Sonic (Shh), Desert (Dhh), and Indian (Ihh) hedgehogs, all of which encode secreted proteins. Among the three, Sonic hedgehog (SHH) is the best studied ligand of the vertebrate pathway. One of the best studied examples is the action of Sonic hedgehog during development of the vertebrate limb, in which both the concentration and the time of exposure to SHH determines which digit into which the tissue will develop4. Stemolecule™ SHH Antagonist is the result of a compound screening for inhibiting activation of the hedgehog signaling pathway, e.g. inhibition of aberrant growth states resulting from phenotypes such as hedgehog gain-of-function1.
Disclaimer
This Stemgent® Product is exclusively distributed by Miltenyi Biotec outside the USA and Israel.
Specifications and technical documents
Specification SheetsMaterial Safety Data Sheets
 
Figure 1
Miltenyi Biotec
Search this website
Services
Customer login
Contact
Newsletter
Favorites / Prices
Request prices or add products to your favorite list.
Details
Products
Stemolecule SHH Antagonist
- 2 mg
- Stemgent Catalog # 04-0032
130-095-582
Qty.:
 

References
1. World Patent WO 2006050351 (2006).
2. Ingham and McMahon (2001) Genes Dev 15: 3059–3087.
3. Jiang and Hui (2008) Dev Cell 15: 801–812.
4. Harfe et al. (2004) Cell 118: 517–528.
MACS Stem Cell newsletter
Stay current with important developments in stem cell research by subscribing to Stem Cell Updates.
 
 
 
 
 
 
 
© 1999 - 2012 Miltenyi Biotec ¦ Terms & conditions ¦ Legal notes
Miltenyi Biotec website